Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Wasman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Surgical Pathology|November 15, 2019
Biallelic PTCH1 Inactivation Is a Dominant Genomic Change in Sporadic Keratocystic Odontogenic TumorsIvan J Stojanov, Inga-Marie Schaefer, Reshma S Menon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2019
Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapyYan Li, Musaddiq J Awan, Tangel Chang, et al.
Laryngoscope Investigative Otolaryngology|August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomasChelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
JCO Oncology Practice|May 11, 2021
African Americans With p16+ and p16- Oropharyngeal Squamous Cell Carcinomas Have Distinctly Poor Treatment Outcomes Independent of Medical Care AccessW Quinn O'Neill, Jay Wasman, Jason Thuener, et al.
Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.
Oral Oncology|April 18, 2022
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomasR Grant Muller, Chelsea S Hamill, Brandon Vu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkersJoseph Baar, Paula Silverman, Janice Lyons, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Cell Reports. Medicine|March 5, 2024
Beta-defensin index: A functional biomarker for oral cancer detectionSantosh K Ghosh, Yuncheng Man, Arwa Fraiwan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Surgical Pathology|November 15, 2019
Biallelic PTCH1 Inactivation Is a Dominant Genomic Change in Sporadic Keratocystic Odontogenic TumorsIvan J Stojanov, Inga-Marie Schaefer, Reshma S Menon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2019
Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapyYan Li, Musaddiq J Awan, Tangel Chang, et al.
Laryngoscope Investigative Otolaryngology|August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomasChelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
JCO Oncology Practice|May 11, 2021
African Americans With p16+ and p16- Oropharyngeal Squamous Cell Carcinomas Have Distinctly Poor Treatment Outcomes Independent of Medical Care AccessW Quinn O'Neill, Jay Wasman, Jason Thuener, et al.
Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.
Oral Oncology|April 18, 2022
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomasR Grant Muller, Chelsea S Hamill, Brandon Vu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkersJoseph Baar, Paula Silverman, Janice Lyons, et al.
Cancers|October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma PatientsKate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Cell Reports. Medicine|March 5, 2024
Beta-defensin index: A functional biomarker for oral cancer detectionSantosh K Ghosh, Yuncheng Man, Arwa Fraiwan, et al.
Pageof 3